Glass House Brands (GLAS) Net Cash Flow (2020 - 2026)
Glass House Brands' (GLAS) quarterly Net Cash Flow came in at $4.6 million in Q1 2026, up 561.42% year-on-year from $692000.0 in Q1 2025, and up 170.76% on a QoQ basis from -$6.5 million in Q4 2025.
Glass House Brands (GLAS) Net Cash Flow (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Net Cash Flow data on file, last reported at $4.6 million in Q1 2026.
- On a quarterly basis, Net Cash Flow rose 561.42% year-over-year to $4.6 million in Q1 2026; TTM through Mar 2026 was -$9.7 million, a 173.71% decrease from a year earlier, with the FY2025 full-year figure at -$13.6 million, down 409.62% from the prior year.
- Net Cash Flow for Q1 2026 stood at $4.6 million, up from -$6.5 million in the prior quarter.
- Over the last five years, Net Cash Flow for GLAS reached as high as $23749.3 billion in Q3 2023 and fell as low as -$14.4 million in Q3 2025.
- Historically, Net Cash Flow has averaged $1498.4 billion across 5 years, with a median of $6.7 million in 2023.
- Across the five-year window, Net Cash Flow soared 152392558.92% in 2023 and sank 447.18% in 2025, its largest moves.
- Year by year, Net Cash Flow stood at $1722.8 billion in 2022, then sank by 100.0% to $8.2 million in 2023, then tumbled by 77.42% to $1.9 million in 2024, then sank by 447.18% to -$6.5 million in 2025, then surged by 170.76% to $4.6 million in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were $4.6 million in Q1 2026, -$6.5 million in Q4 2025, and -$14.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -277.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | 4.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.58 Mn |
| Mar 31, 2026 | 4.58 Mn |
| Dec 31, 2025 | -6.47 Mn |
| Dec 31, 2025 | -6.47 Mn |
| Sep 30, 2025 | -14.43 Mn |
| Sep 30, 2025 | -14.43 Mn |
| Jun 30, 2025 | 6.59 Mn |
| Jun 30, 2025 | 6.59 Mn |
| Mar 31, 2025 | 692,000.00 |
| Mar 31, 2025 | 692,000.00 |
| Dec 31, 2024 | 1.86 Mn |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 9.18 Mn |
| Sep 30, 2024 | 9.18 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | -8.12 Mn |
| Mar 31, 2024 | -8.12 Mn |
| Dec 31, 2023 | 8.25 Mn |
| Dec 31, 2023 | 8.25 Mn |